Sign Out
The recommended dose should not be exceeded. Consult the doctor if the symptoms persist.
Efficacy and safety of bilastine in children under 12 years of age have not been established.
In patients with moderate or severe renal impairment concomitant intake of bilastine with P-glycoprotein inhibitors, such as e.g. ketoconazole, erythromycin, cyclosporine, ritonavir or diltiazem, may increase plasmatic levels of bilastine and therefore increase the risk of adverse effects of bilastine. Therefore, concomitant intake of bilastine and P-glycoprotein inhibitors should be avoided in patients with moderate or severe renal impairment.
